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ABSTRACT 
α-Iodoaziridines are unusual motifs and intriguing structures for further functionalisation of the intact aziridine. The preparation of N-protected α-
iodoaziridines is achieved through an addition-cyclisation reaction of LiCHI2 with imines. The effects of varying the N-group and using different 
carbenoids are investigated. Excellent cis-stereochemistry is achieved, except for N-carbamates containing aryl groups. Using the mixed carbenoid 
LiCHICl, the iodide leaving group is selected for cyclisation affording chloroaziridines only, as a cis/trans mixture. More convenient and higher 
yielding conditions for the preparation of alkyl N-Ts α-iodoaziridines are developed, using ClMgCHI2. Additionally, the formation of the problematic 
primary alkyl α-iodoaziridines is achieved. 
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1. Introduction 
Aziridines are important motifs in organic chemistry as a result of the inherent strain in the 3-membered heterocycle.1 This feature is 
central to their use as synthetic intermediates in ring opening processes to provide important nitrogen-containing compounds,2,3 and also 
to the mode of biological action of aziridine containing natural products.4 For the synthetic chemist the small ring structure of aziridines 
is a fascinating target for new methodology development, and there continues to be important advances in the stereoselective synthesis 
of aziridines.5 Conceptually there are several strategies for the preparation of aziridine derivatives. These include the transfer of 
carbenoid reagents or equivalents to imines.6 The direct nitrogen transfer to alkenes can be achieved using nitrenoid derivatives.7 
Aziridines can also be accessed by cyclisation of β-functionalised amines,8 which may be formed effectively via addition of 
nucleophiles to α-haloimines.9 An alternative, divergent strategy is to prepare an aziridine by one of these approaches, and then to 
couple that intact aziridine, forming a bond directly to the aziridine ring.10 This has been achieved by metalation of aziridines and 
reaction with electrophiles,11,12 as well as palladium-catalysed cross-coupling of the intact aziridines.13 
Inspired by this latter approach, we hypothesised that iodo-substituted aziridines might provide interesting precursors for the further 
functionalisation of intact aziridine rings. Towards this goal, we have recently developed protocols for the synthesis of N-Boc14 and N-
Ts15 α-iodoaziridines, the first examples of this functional group (Scheme 1A). Both of these methods employ the addition of 
diiodomethyllithium, formed via the deprotonation of diiodomethane with LiHMDS, to N-protected imines, often formed in situ from 
their sulfinic acid adducts, followed by highly stereoselective cyclisation. 
 
Scheme 1. Synthesis of α-iodoaziridines and functionalisation via aziridinyllithium. 
 
The formation of N-Boc α-iodoaziridines was successful for aryl substituted imines.14 With N-Ts imines, both alkyl and aryl 
substituted α-iodoaziridines could be accessed in moderate to good yields, though unbranched, primary alkyl imines only afforded very 
low yields.15a The temperature at which cyclisation occurred varied depending on the nature of the N-protecting group, but excellent cis-
selectivity was achieved in all cases. These α-iodoaziridines were shown to be stable on isolation and could be purified by 
chromatography when the stationary phase was judiciously selected.15 Furthermore, we demonstrated that N-Ts α-iodoaziridines could 
be used to generate aziridinyllithium species by Li–I exchange (Scheme 1B).16  The aziridinyllithium was then trapped with 
electrophiles, affording N-sulfonyl aziridine derivatives in high yields and with complementary regio- and stereochemistry to 
deprotonation approaches. 
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Halomethylmetal reagents, in particular chloromethyllithium, have received significant attention in synthetic chemistry, as they can 
display both nucleophilic and electrophilic reactivity.17,18,19 Dihalomethylmetal reagents have been investigated to a lesser degree.20,21,22 
Integral to the approach to α-iodoaziridines has been the use of diiodomethyllithium.14,15 Unlike traditional aza-Darzens reactions, 
whereby the diastereoselectivity of aziridine products is determined in the initial carbenoid addition step, here due to the symmetrical 
nature of LiCHI2, the cyclisation step is diastereodetermining. We considered that using alternative reagents (changing either the nature 
of the N-group, or the nature of the carbenoid reagent (MCHI2)), could afford a different stereochemical outcome, provide improved 
yields for the more challenging substrates, or provide insight into the factors that affect stereoselectivity.  
Here we report our investigations into the effect of variation of the N-protecting group and the carbenoid reagents employed in the 
synthesis of α-iodoaziridines, and relevance to the stereochemical outcome. We report an improved procedure for the preparation of 
alkyl substituted N-Ts α-iodoaziridines with improved yields, through the use of ClMgCHI2, and study the problematic unbranched 
primary alkyl α-iodoaziridine examples. 
2. Results and Discussion 
2.1. Role of N-protecting group 
We first assessed the effect of changing the N-protecting group on the α-iodoaziridine reaction, using imines formed from 
benzaldehyde. Diiodomethyllithium was formed by deprotonation of CH2I2 with LiHMDS over 20 min in a THF/Et2O mixture at −78 
°C, prior to the addition of the imine–HSO2Tol adduct. Within the carbamate series (2.4 equiv CH2I2, 2.6 equiv LiHMDS), the reaction 
with the N-Boc imine gave 83% isolated yield of α-iodoaziridine 1.14 The reaction required warming to 30 °C to give full cyclisation 
and prevent elimination from the intermediate diiodide.23 Only the cis-α-iodoaziridine was observed. In moving to the ethyl and methyl 
carbamates, the products (2 and 3 respectively) were obtained in reduced yields, presumably due to attack of the nucleophile at the 
carbonyl. However, very high diastereoselectivity was maintained, despite the decrease in steric bulk; again only the cis–product was 
observed. Rapid warming from −78 °C to ambient temperatures was required to minimize the formation of unwanted side products and 
to ensure full cyclisation of the amino gem-diiodide intermediates. The reaction with phenyl carbamate yielded a complex mixture of 
products. The imine formed from N-benzyl carbamate also afforded a complicated mixture of products under the reaction conditions. 
Elimination of iodide from the gem-diiodide intermediate to form the corresponding vinyl iodide was a major reaction pathway. The 
Cbz-protected α-iodoaziridine 4 was observed in the 1H NMR spectrum of the crude reaction mixture, as a mixture of diastereoisomers 
(cis:trans, 2.5:1), but could not be isolated (CHI: cis, δ 4.76, J = 5.4 Hz vs. trans, δ 4.31, J = 1.9 Hz). In both cases, isolation of 
aziridine-like products proved problematic, with decomposition apparent on a variety of stationary phases. Interestingly, the use of the 
benzoyl N-protecting group (COPh) led to a reverse in the diastereoselectivity of the cyclisation step, with the trans-product now the 
major product 5 (trans:cis = 2.4:1). Unfortunately, decomposition again occurred on attempted purification and the aziridine products 
could not be isolated. 
  
Scheme 2. Effect of N-protecting group on α-iodoaziridine formation. a Reaction conditions: imine–HO2STol adduct (0.50-0.65 
mmol), CH2I2 (3.0 equiv), LiHMDS (2.6 equiv), THF:Et2O (3:1), –78 ºC (10 min), then warm (10 min). b Product not isolated, 
unstable to chromatography . c Reaction conditions: imine (0.50 mmol), CH2I2 (3.4 equiv), LiHMDS (3 equiv), THF:Et2O (3:1), –
78 ºC (10 min), then warm (15 min). 
 
Our hypothesis for the cis-stereochemical outcome of the cyclisation is that interactions of the non-displaced iodide with the N-
protecting groups disfavour the trans-aziridine cyclisation transition state (Scheme 1A).14 In all of the cases depicted in Scheme 2, we 
observed exclusively the cis-α-iodoaziridines, apart from when N-groups containing aromatic rings were employed (Cbz and 
benzylamide). This suggests a favourable π-π interaction between the aryl groups may be occurring, promoting formation of the trans-
compound in these cases. 
We next assessed bulky sulfonyl protecting groups, under slightly different reaction conditions; 1.0 equiv imine, 3.4 equiv CH2I2, 3.0 
equiv LiHMDS. We had previously reported N-Ts α-iodoaziridine 6, formed in 76% on warming the reaction mixture to 0 ºC to 
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promote cyclisation, exclusively as the cis-aziridine. The tert-butylsulfonyl protecting group, in similar fashion, also gave rise 
exclusively to the cis-α-iodoaziridine 7 in 45% yield. 
2.2. Mixed halo-carbenoids: chloroiodomethyllithium 
Reacting LiCHBr2, in place of LiCHI2, with imine−HSO2Tol adduct 8 afforded cis-N-Boc bromoaziridine 9 in 30% yield (Scheme 3).14 
Deyrup demonstrated that chloroaziridines also show a complete preference for cis-stereochemistry.20 However, mixed dihalocarbenoid 
systems of the form LiCHXY (X≠Y) have not been previously investigated, posing interesting questions about the reactivity of the 
proposed intermediate and the diastereoselectivity. Chloroiodomethane was chosen as a suitable carbenoid precursor to investigate this, 
due to cost and availability. Being unsymmetrical, the initial nucleophilic addition of LiCHICl would determine the relative 
stereochemistry of a particular product, however, there would be a choice for the cyclisation. Preference for cis-configuration in the 
aziridine products would give a mixture of cis-chloro and cis-α-iodoaziridines. On the other hand, preference for the displacement of 
iodide from the dihalogenated intermediate as the better leaving group would give exclusively chloroaziridines, as a mixture of cis- and 
trans-substituted products.  
  
Scheme 3. Effect of using mixed dihalocarbenoids on chemo- and diastereoselectivity in formation of α-haloaziridines. 
 
To test this, using phenyl N-Boc imine precursor 8, LiCHICl was formed using LiHMDS and CH2ICl under reaction conditions 
developed for α-iodoaziridines (Scheme 3). Both cis- and trans-substituted α-chloroaziridines were formed (10 and 11), but none of the 
corresponding α-iodoaziridines (CHCl: cis, δ 4.77, J = 5.1 Hz vs. trans, δ 4.53, J = 1.8 Hz). This indicated a preference for the system 
to displace the better leaving group, rather than for the cis-stereochemistry. However, the yield for the cis-product was higher than that 
for the trans (dr = 3.3:1 10:11 in crude reaction mixture). The intermediate dihalides (12) were formed in 1.6:1 dr when the reaction 
was quenched at low temperature, and were isolated in low yield.24 The dr enhancement in the formation of the cis-α-chloroaziridine, 
suggests that the cyclisation to the cis-product may remain a lower energy pathway. Finally, the observation of aminal species 13, 
suggests the chloroiodomethane is not fully deprotonated under the reaction conditions. The corresponding product was also observed 
in our studies with N-Ts α-iodoaziridines.15  
 
2.3. Using diiodomethylmagnesium: an improved protocol for the preparation of alkyl-α-iodoaziridines.  
In our studies to date, the use of LiHMDS to deprotonate diiodomethane had provided the highest yield of α-iodoaziridines. In the 
synthesis of N-Ts α-iodoaziridines, the addition of LiHMDS directly to the imine was a significant side product,25 implying incomplete 
deprotonation of diiodomethane in the 20 min reaction time prior to addition of the imine. This was confirmed by deuteration studies, 
whereby treatment of diiodomethane with LiHMDS under our standard protocol and quenching with d4-MeOD after 20 minutes, 
revealed only 30% D-incorporation. However, increasing the deprotonation time led to lower overall yields of α-iodoaziridines. 
Furthermore, the presence of the aminal side-product required a more involved purification of the α-iodoaziridines. Degradation of the 
aminal to benzaldehyde occurred upon silica gel, which co-eluted with the desired N-Ts α-iodoaziridines during chromatography. 
Therefore purification was performed with deactivated basic alumina.  
Due to ongoing further studies using the N-Ts α-iodoaziridines in particular, we required multi gram-quantities of alkyl N-Ts α-
iodoaziridines. Consequently, a more facile procedure to improve both the yield and ease of purification of the reaction was required. 
Therefore we examined alternative protocols for the formation of MCHI2 reagents, where full formation of the reagent could be 
achieved. 
Table 1. Optimisation of improved procedure for N-Ts α-iodoaziridine formation varying diiodomethyl-metal rea-gents. 
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3 CHI3 (4.0) MeLi (4.0) 0e 
4 CHI3 (4.0) i-PrMgCl (4.0) 75 
5 CHI3 (4.0) EtMgCl (4.0) 87 
6 CHI3 (3.0) EtMgCl (3.0) 85 
a Reaction conditions unless specified: imine–HO2STol adduct (0.50 mmol), CHI3, R-M, THF (0.26 M at exchange), –78 ºC to 0 ºC.  b Yield determined by 1H 
NMR spectroscopy with reference to an internal standard (1,3,5-trimethoxybenzene). c Reaction conditions: imine–HO2STol adduct (0.50 mmol), n-BuLi (2.00 
mmol), HMDS (2.00 mmol), CH2I2 (2.20 mmol), THF:Et2O (0.16 M at deprotonation), –78 ºC to 0 ºC. d Isolated yield.  
e Diiodoethane formed (see Equation 1). 
Under the standard conditions involving deprotonation of CH2I2, a 63% yield of α-iodoaziridine 15 was obtained (Table 1, entry 1).15 
The product could also be obtained starting from iodoform, employing n-BuLi at low temperature to generate diiodomethyllithium by 
Li–I exchange, over 3 min prior to the addition of the imine (entry 2). While the yield was comparable, in the absence of LiHMDS, we 
found that α-iodoaziridine 15 could now be purified using conventional silica gel chromatography. Using MeLi provided no desired α-
iodoaziridine under the reaction conditions (entry 3). Interestingly 1,1-diiodoethane (16) was observed as the only reaction product due 
to the reaction of MeI with diiodomethyllithium after the initial Li–I exchange with iodoform (Equation 1). 
 
Next we considered magnesium carbenoids, which display similar reactivity to lithium carbenoids but may show increased thermal 
and configurational stability.17b,c,26 Methodology developed by Seyferth and Lambert18b to form ClMgCHI2 by Mg−I exchange between 
iodoform and i-PrMgCl at low temperature, has recently been adapted by Schmidt for addition to aldehydes.26a Formation of ClMgCHI2 
using 4.0 equiv of both i-PrMgCl and CHI3 at –78 ºC, followed by addition of the imine precursor 14 and cyclisation by warming (10 
min, −78 °C, then 15 min, 0 °C) was very promising (entry 4). We observed an improved yield of 75% for α-iodoaziridine 15. This was 
further improved when employing EtMgCl under otherwise identical reaction conditions (entry 5). Finally, we were able to reduce the 
equivalents of both iodoform and EtMgCl (entry 6), and maintain a good yield of 15. The previously employed dual solvent system 
(THF/Et2O) was not required for the formation and stability of the magnesium carbenoid, meaning THF alone could be used, 
simplifying the protocol. α-Iodoaziridine 15 was isolated in 85% yield on 3 mmol scale (vs 63% using LiCHI2).15 These improved 
conditions were applied to other secondary and tertiary-alkyl N-Ts imines enabling the preparation of N-Ts α-iodoaziridines 17 and 18 
in high yield and purity, exclusively as their cis-diastereoisomers (Scheme 4). Notably the excellent cis-stereoselectivity remained for 
the tert-butyl example 18. 
 
Scheme 4. Scope of secondary alkyl substituted α-iodoaziridines utilizing Mg-carbenoids. Reaction conditions: imine−HO2STol 
adduct/imine (3.00 mmol), CHI3 (9.00 mmol), EtMgCl (9.00 mmol), THF (0.26 M at exchange), –78 ºC to 0 ºC. 
 
Next we examined the effect of employing ClMgCHI2 with chiral imine 19, bearing Ellman’s auxiliary (Scheme 5). Using LiCHI2 
gave rise to a mixture of two enantiopure cis-α-iodoaziridines, 20 and 21, in an 85:15 diastereomeric ratio.15a Treatment of imine 19 
with ClMgCHI2 afforded a mixture of aziridines 20 and 21, exclusively the cis-diastereoisomers. The major isomer 20 was the same in 
both cases, here with a reduced 71:29 ratio of diastereoisomers. The addition is proposed to occur via an open transition state.27 With 
the Grignard reagent, a chelated, cyclic transition state is plausible, which is likely to reduce the dr, though not dominate due to 
competing coordination of the THF solvent.  
 
Scheme 5. Effect of changing MCHI2 reagent on the reaction with chiral imines.  
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2.4. Primary alkyl α-iodoaziridines.  
Under our reaction conditions for the formation of N-Ts α-iodoaziridines, primary alkyl imine-sulfinic acid adducts suffered from 
very poor yields and competing nucleophilic addition by LiHMDS, (6% yield for the imine derived from butanal, Scheme 6A). 
However, generating LiCHI2 by Li–I exchange using n-BuLi/CHI3 only gave a very slight improvement in yield (13% as determined by 
1H NMR). We were pleased to find that the use of diiodomethylmagnesium chloride afforded excellent conversion of imine precursor 
25 to the corresponding diiodide 26 after 15 min at 0 °C, though only minor conversion to α-iodoaziridine 27 was observed (Scheme 
6B). However, a sampling study indicated that while prolonged reaction times at 0 °C did increase conversion to α-iodoaziridine 27, the 
rate of cyclisation was slow and the desired α-iodoaziridine product rearranged to iodo-imine 29 (Scheme 7).28 
 
Scheme 6. Formation of primary alkyl α-iodoaziridines using ClMgCHI2. 
 
 
Scheme 7. Postulated mechanism for rearrangement of α-iodoaziridine 27 to iodo-imine 29. 
 
This rearrangement is presumed to occur via a unimolecular aziridine-ring opening process, affording cation 28,29 which is 
subsequently trapped with iodide affording iodo-imine 29. Similar aziridine rearrangements have previously been reported by Yudin, 
converting bromoaziridines to bromohydrazones,30 and ourselves in the rearrangement of electron rich N-Ts α-iodoaziridines to iodo-
imines.15a,31 Attempting to control the conversion to the desired α-iodoaziridine and prevent rearrangement to the corresponding iodo-
imine, we examined the influence of reaction time at different temperatures with imine−HSO2Tol adduct 22 (Table 2). 
Table 2. Optimisation of improved procedure for primary N-Ts α-iodoaziridine using ClMgCHI2. 
 
entry a T1 / °C t1 (min) 
yield (%)b 
30 23 31 
1 0 15 81 16 0 
2 0 30 77 22 0 
3 0 45 69 31 0 
4 15 15 41 18 5 
5 30 15 15 7 10 
a Reaction conditions: imine–HO2STol adduct (0.50 mmol), CHI3 (4.0 equiv), i-PrMgCl (4.0 equiv), THF (0.26 M at exchange). b Yield determined by 1H 
NMR spectroscopy with reference to an internal standard (1,3,5-trimethoxybenzene).  
Increasing the time at 0 ºC from 15 min to 45 min led to an increase in the proportion of cyclised product (entries 1-3). However, 
increased times led to degradation and rearrangement. Unfortunately, warming to 15 °C (entry 4), led to significant degradation of the 
reaction mixture, with a lower recovery observed. The thermal instability of the reaction mixture was further evident with warming to 
30 °C for 15 min (entry 5), with α-iodoaziridine 23 rearranging to iodo-imine 31. 
We therefore examined the possibility of isolating diiodide 30 to perform cyclisation in a second step. Under conditions outlined in 
Table 2 (entry 1), the crude reaction mixture (5:1 30:23) was subjected to purification using deactivated basic alumina (activity IV). To 
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our surprise, this resulted in cyclization to the desired α-iodoaziridine, promoted by the basic solid phase, in a modest, but much 
improved, 44% yield (Scheme 8).  
 
Scheme 8. Formation of primary alkyl N-Ts α-iodoaziridine 23 via treatment with deactivated basic alumina (activity IV). 
 
Pleasingly this was similarly successful with imine adduct 25 (Scheme 9). With warming to 0 ºC we observed minimal cyclisation in 
the crude reaction mixture with diiodide 26 as the major product. Passing this mixture through a column of basic alumina (activity IV) 
again promoted cyclisation to the desired α-iodoaziridine 27 in a 44% isolated yield. Small quantities of remaining diiodide 26 were 
also isolated. This approach represents a significant improvement to the reaction protocol for primary imines versus the same imine–
HSO2Tol adduct with LiCHI2, which only yielded 6% of corresponding α-iodoaziridine 23. 
 
Scheme 9. Formation of primary alkyl N-Ts α-iodoaziridine 27 via treatment with deactivated basic alumina (activity IV). 
 
3. Conclusion 
In conclusion we have demonstrated that a variety of N-groups (carbamate, sulfonyl and sulfinyl) are suitable for the synthesis of α-
iodoaziridines, often in excellent cis-selectivity. The exception is when carbamates contain aromatic rings, which afforded an increase 
in the trans-product possibly due to π-π interactions. The use of LiCHICl also led to the formation of aziridines, as a mixture of cis and 
trans-chloroaziridines. The corresponding iodides are not observed indicating a strong preference for cyclisation through the better 
leaving group, rather than an essential preference for cis-stereochemistry. These observations are supportive of our model that the usual 
cis preference is due to unfavourable steric interactions in the transition state that would lead to the trans-product.  
The use of ClMgCHI2 has been shown to be superior to the use of LiCHCI2 for the synthesis of alkyl N-Ts α-iodoaziridines. A 
modified, more straightforward procedure provided improved yields and workup procedure. The perfect cis-selectivity is maintained. 
This protocol has enabled the synthesis of primary, secondary and tertiary alkyl substituted α-iodoaziridines. Further reactivity of these 
α-iodoaziridines will be reported in due course.  
4. Experimental Section 
All nonaqueous reactions were run under an inert atmosphere (argon) with flame-dried glassware using standard techniques. Anhydrous 
solvents were obtained by filtration through drying columns (THF, Et2O, CH2Cl2, hexane). Flash column chromatography was 
performed using 230-400 mesh silica or 50-200 µm Brockmann basic alumina (activity IV) with the indicated solvent system according 
to standard techniques. Analytical thin-layer chromatography (TLC) was performed on precoated, glass-backed silica gel plates. 
Visualisation of the developed chromatogram was performed by UV absorbance (254 nm), aqueous potassium permanganate stain, 
ninhydrin solution in ethanol, phosphomolybdic acid solution in ethanol, or a vanillin solution. Infrared spectra (νmax, FTIR ATR) were 
recorded in reciprocal centimeters (cm-1). Nuclear magnetic resonance spectra were recorded on 400 MHz spectrometers. Chemical 
shifts for 1H NMR spectra are recorded in parts per million from tetramethylsilane with the solvent resonance as the internal standard 
(chloroform, δ = 7.27 ppm). Data is reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet 
and br = broad), coupling constant in Hz, integration, assignment]. 13C NMR spectra were recorded with complete proton decoupling. 
Chemical shifts are reported in parts per million from tetramethylsilane with the solvent resonance as the internal standard (13CDCl3: 
77.0 ppm). J values are reported in Hz. Assignments of 1H/13C spectra were made by the analysis of δ/J values, and COSY, HSQC, and 
HMBC experiments as appropriate. α-Iodoaziridines and diiodides decomposed upon heating (>100 °C), therefore accurate melting 
points have not been determined. Reagents: HMDS was freshly distilled over KOH pellets under an Ar atmosphere prior to use. All 
other commercial reagents were used as supplied, or purified by standard techniques where necessary. Procedure for obtaining 
deactivated basic alumina: Commercial alumina is classed as activity I. To alter the activity to basic alumina (activity IV), 10% w/v 
water must be added to basic alumina (activity I) and evenly distributed.15,32 Imine synthesis: N-Carbamate imine–HSO2Tol adducts 
were prepared according to the procedure of Jacobsen.33 N-[(E)-Phenylmethylidene]-4-methyl-benzenesulfonamide was prepared 
according to the method of Chemla.34,15 2-Methyl-N-(phenylmethylidene)-propane-2-sulfonamide was prepared by oxidation of (R)-(+)-
2-methyl-N-(phenylmethylidene)propane-2-sulfinamide 1935 according to the procedure of Ruano.36 
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4.1. General Procedure A: Synthesis of N-carbamate α-Iodoaziridines using LiHMDS. 
Diiodomethane (145 µL, 1.80 mmol, 3.0 equiv) in THF (1.6 mL) was added dropwise to a solution of LiHMDS (1 M solution in 
THF, 1.56 mL, 1.56 mmol, 2.6 equiv) in THF (6.0 mL) and Et2O (3.0 mL) at –78 °C in the dark. After 20 minutes at −78 °C, a solution 
of the imine−HSO2Tol adduct (0.60 mmol, 1.0 equiv) in THF (2.0 mL) was added dropwise to the reaction mixture. After 10 minutes at 
−78 °C, the reaction flask was transferred to a water bath at the specified temperature for 10 minutes and then quenched by the addition 
of saturated aqueous sodium bicarbonate solution (30 mL). The aqueous mixture was extracted with CH2Cl2 (3 × 30 mL). The organic 
extracts were combined, dried (Na2SO4), filtered and the solvent removed under reduced pressure. Purification by flash chromatography 
afforded the cis-α-iodoaziridine. 
4 .1 .1 .  c is - (±) -2- Iodo-3-pheny l -1 - ter t -bu toxycarbony laz i r id ine  (1 ) .   
Prepared according to General Procedure A described above, starting from imine–HO2STol adduct 8 (217 mg, 0.60 mmol), warming to 
30 °C. Purification by flash chromatography (10% Et2O/hexane) afforded cis-α-iodoaziridine 1 (172 mg, 83%) as a colourless oil: Rf = 
0.37 (20% Et2O/hexane); νmax (film)/cm-1 2981, 1724 (C=O), 1610, 1496, 1478, 1458, 1399, 1372, 1320, 1306, 1285, 1258, 1230, 1147, 
1078, 1029; 1H NMR (400 MHz, CDCl3) δ 7.43–7.34 (m, 5H, 5 × Ph-H), 4.72 (d, J = 5.4 Hz, 1H, CHI), 3.59 (d, J = 5.4 Hz, 1H, CHPh), 
1.51 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 159.6 (C=O quat.), 134.8 (Ph-C quat.), 128.4 (Ph-C), 128.0 (2 × Ph-C), 127.5 (2 
× Ph-C), 82.9 (C(CH3)3 quat.), 43.1 (PhCHN), 27.9 (C(CH3)3), 18.2 (CHI); HRMS (ESI+) m/z Calculated for C13H17INO2+ [M+H]+: 
346.0298; Found: 346.0295. 
4 .1 .2 .  c is - (±) -2- Iodo-3-pheny l -1 -e thoxycarbony laz i r id ine  (2 ) .   
Prepared according to General Procedure A described above, starting from [(phenyl-(toluene-4-sulfonyl)-methyl]-ethyl-carbamate 
(200 mg, 0.60 mmol, 1.0 equiv), warming to rt. Purification by flash chromatography (10% Et2O/hexane) afforded cis-α-iodoaziridine 2 
(114 mg, 60%) as a colourless oil: Rf = 0.32 (20% EtOAc/hexane); νmax (film)/cm-1 2989, 1727 (C=O), 1610, 1458, 1401, 1369, 1301, 
1268, 1226, 1183, 1100, 1025, 757, 698; 1H NMR (400 MHz, CDCl3) δ 7.43–7.34 (m, 5H, 5 × Ph-H), 4.76 (d, J = 5.4 Hz, 1H, CHI), 
4.29 (q, J = 7.1 Hz, 2H, OCH2CH3), 3.65 (d, J = 5.4 Hz, 1H, CHPh), 1.34 (t, J = 7.1 Hz, 3H, OCH2CH3); 13C NMR (101 MHz, CDCl3) 
δ 160.8 (C=O quat.), 134.4 (Ph-C quat.), 128.5 (Ph-C), 128.1 (2 × Ph-C), 127.4 (2 × Ph-C), 63.4 (OCH2CH3), 43.2 (PhCHN), 17.8 
(CHI), 14.3 (OCH2CH3); HRMS (ESI+) m/z Calculated for C11H13INO2+ [M+H]+: 317.9991; Found: 317.9998. 
4 .1 .3 .  c is - (±) -2- Iodo-3-pheny l -1 -methoxycarbony laz i r id ine  (3 ) .  
Prepared according to General Procedure A described above, starting from [(phenyl-(toluene-4-sulfonyl)-methyl]-methyl-
carbamate37 (202 mg, 0.63 mmol), warming to rt. Purification by flash chromatography (10% Et2O/hexane) afforded cis-α-iodoaziridine 
3 (107 mg, 56%) as a colourless oil: Rf  = 0.32 (20% EtOAc/hexane); νmax (film)/cm-1 2956, 1725 (C=O), 1508, 1437, 1403, 1319, 1301, 
1270, 1225, 1196, 1015, 963, 915, 813, 750, 698; 1H NMR (400 MHz, CDCl3) δ 7.41–7.34 (m, 5H, 5 × Ph-H), 4.77 (d, J = 5.4 Hz, 1H, 
CHI), 3.83 (s, 3H, OCH3), 3.67 (d, J = 5.4 Hz, 1H, CHPh); 13C NMR (101 MHz, CDCl3) δ 161.2 (C=O quat.), 134.2 (Ph-C quat,), 128.5 
(Ph-C), 128.1 (2 × Ph-C), 127.4 (2 × Ph-C), 54.1 (OCH3), 43.2 (PhCHN), 17.6 (CHI); HRMS (ESI+) m/z Calculated for C10H11INO2 
[M+H]+: 303.9834; Found: 303.9848. 
4 .1 .4 .  c is - (±) -2-Bromo-3-pheny l -1 - ter t -bu toxycarbony laz i r id ine  (9 ) .  
Prepared according to General Procedure A described above, starting from dibromomethane (126 µL, 1.80 mmol, 3.0 equiv) and 
imine−HSO2Tol adduct 8 (217 mg, 0.60 mmol, 1.0 equiv), warming to 30 °C. Purification by flash chromatography (10% 
EtOAc/hexane) afforded cis-α-bromoaziridine 9 (53 mg, 30%) as a colourless oil: Rf = 0.25 (10% EtOAc/hexane); νmax (film)/cm-1 
2982, 1726 (C=O), 1303, 1279, 1257, 1233, 1156, 907, 730, 698; 1H NMR (400 MHz, CDCl3) δ 7.43–7.35 (m, 5H, 5 × Ph-H), 4.87 (d, 
J = 5.1 Hz, 1H, CHBr), 3.75 (d, J = 5.1 Hz, 1H, CHPh), 1.52 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 159.3 (C=O quat.), 133.2 
(Ph-C quat.), 128.4 (Ph-C), 128.0 (2 × Ph-C), 127.8 (2 × Ph-C), 83.0 (C(CH3)3 quat.), 44.7 (CHBr), 44.1 (CHN), 27.9 (C(CH3)3); 
HRMS (CI) m/z Calculated for C13H1779Br NO2+ [M+H]+: 298.0443; Found: 298.0450. 
4 .1 .5 .  c is - (±) -2-Chloro-3-pheny l -1 - ter t -bu toxycarbony laz i r id ine  (10 )  and  t rans- (±) -2-ch loro-3-pheny l -1 -
ter t -bu toxycarbony laz i r id ine  (11 ) .   
Prepared according to General Procedure A described above, starting from chloroiodomethane (131 µL, 1.80 mmol, 3.0 equiv) and 
imine−HSO2Tol adduct 8 (217 mg, 0.60 mmol, 1.0 equiv), warming to 30 °C. Purification by flash chromatography (hexane grading to 
10% EtOAc/hexane) afforded trans-α-chloroaziridine 11 (11 mg, 7%) as a yellow oil, followed by cis-α-chloroaziridine 10 (55 mg, 
36%) as a yellow oil. 
11: Rf = 0.44 (10% EtOAc/hexane); νmax (film)/cm-1 2878, 1726 (C=O), 1483, 1457, 1394, 1369, 1309, 1252, 1228, 1154, 1080, 
1042, 942, 841, 733, 697; 1H NMR (400 MHz, CDCl3) δ 7.36–7.33 (m, 3H, 3 × Ph-H), 7.27–7.25 (m, 2H, 2 × Ph-H), 4.53 (d, J = 1.8 
Hz, 1H, CHCl), 3.67 (d, J = 1.8 Hz, 1H, CHPh), 1.42 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 156.9 (C=O quat.), 133.7 (Ph-C 
quat.), 128.64 (Ph-C), 128.62 (2 × Ph-C), 126.8 (2 × Ph-C), 82.9 (C(CH3)3 quat.), 52.1 (CHCl), 477 (CHN), 27.8 (C(CH3)3); HRMS 
(CI) m/z Calculated for C13H20ClN2O2+ [M+NH4]+: 271.1206; Found: 271.1213. 
10: Rf = 0.30 (10% EtOAc/hexane); νmax (film)/cm-1 2982, 1728 (C=O), 1396, 1370, 1321, 1283, 1257, 1150, 853, 748, 696; 1H 
NMR (400 MHz, CDCl3) δ 7.42–7.35 (m, 5H, 5 × Ph-H), 4.77 (d, J = 5.1 Hz, 1H, CHCl), 3.78 (d, J = 5.1 Hz, 1H, CHPh), 1.52 (s, 9H, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 159.4 (C=O quat.), 132.3 (Ph-C quat.), 128.3 (Ph-C), 128.1 (2 × Ph-C), 127.9 (2 × Ph-C), 
83.0 (C(CH3)3 quat.), 54.4 (CHCl), 44.9 (CHN), 27.9 (C(CH3)3); HRMS (CI) m/z Calculated for C13H17ClNO2+ [M+H]+: 254.0948; 
Found: 254.0946. 
4.2. General Procedure B: Synthesis of N-Sulfonyl α-Iodoaziridines using LiHMDS. 
n-BuLi (1.50 mmol, 3.0 equiv) was added dropwise to a solution of hexamethyldisilazane (315 µL, 1.50 mmol, 3.0 equiv) in THF (5.7 
mL) and Et2O (2.7 mL) at –78 °C. After 30 minutes, diiodomethane (135 µL, 1.70 mmol, 3.4 equiv) in THF (1.0 mL) was added 
dropwise to the reaction mixture at –78 °C in the dark. After 20 minutes at −78 °C, a solution of the appropriate imine (0.50 mmol, 1.0 
equiv) in THF (2.0 mL) was added dropwise to the reaction mixture over 5 minutes. The reaction was then immediately warmed to 0 °C 
in an ice bath and left at this temperature for 15 minutes. The reaction was then quenched by the addition of saturated aqueous sodium 
bicarbonate solution (40 mL). The aqueous solution was extracted with CH2Cl2 (3 × 30 mL), then the combined organic layers were 
dried (Na2SO4), filtered and the solvent removed under reduced pressure. Purification by flash chromatography on deactivated basic 
alumina (activity IV or activity V) afforded the cis-α-iodoaziridine. 
4 .2 .1 .  c is - (±) -2- Iodo-3-pheny l -1 - (4 - to ly l su l fony l )az i r id ine  (6 ) .  
Prepared according to General Procedure B described above, starting from N-[(E)-phenylmethylidene]-4-methyl-benzene-sulfonamide 
(130 mg, 0.50 mmol). Purification by flash chromatography (10% EtOAc/hexane) on deactivated basic alumina (activity IV) afforded 
cis-α-iodoaziridine 6 (152 mg, 76%) as a yellow oil: Rf = 0.24 (15% Et2O/hexane); νmax (film)/cm-1 3035, 2928, 1600, 1499, 1453, 
1330, 1157, 1088, 902, 813, 763, 727, 696, 683, 666; 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.5 Hz, 2H, 2 × SO2Tol-H), 7.42−7.33 
(m, 5H, 3 ×Ph-H and 2 × SO2Tol-H), 7.31−7.25 (m, 2H, 2 × Ph-H), 4.89 (d, J = 6.1 Hz, 1H, CHI), 3.89 (d, J = 6.1 Hz, 1H, CHPh), 2.47 
(s, 3H, CH3); 13C NMR (101 MHz, CDCl3) δ 145.3 (SO2C-Tol quat.), 134.1 (SO2TolC-CH3 quat.), 132.9 (PhC quat.), 129.9 (2 × 
SO2Tol-C), 128.7 (Ph-C), 128.1 (2 × SO2Tol-C), 127.8 (2 × Ph-C), 127.5 (2 × Ph-C), 44.9 (PhCN), 21.7 (SO2Tol-CH3), 16.4 (CHI); 
HRMS (ESI+) m/z Calculated for C15H15INO2S+ [M+H]+ 399.9863; Found 399.9856. 
4 .2 .2 .  c is - (±) -2- Iodo-1- (2-methy lpropane-2-su l fony l ) -3 -pheny laz i r id ine  (7 ) .   
Prepared according to General Procedure B described above, starting from 2-methyl-N-(phenylmethylidene)propane-2-sulfonamide 
(113 mg, 0.50 mmol). Purification by flash chromatography (5% EtOAc/hexane) on deactivated basic alumina (activity IV) afforded 
cis-α-iodoaziridine 7 (82 mg, 45%) as a yellow oil: Rf = 0.24 (15% Et2O/hexane); νmax (film)/cm-1 2987, 1457, 1314, 1249, 1175, 1126, 
905, 862, 765, 730, 699, 670; 1H NMR (400 MHz, CDCl3) δ 7.46−7.35 (m, 5H, 5 × Ph-H), 4.90 (d, J = 6.0 Hz, 1H, CHI), 3.86 (d, J = 
6.0 Hz, 1H, CHPh), 1.58 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 133.1 (Ph-C quat.), 128.9 (Ph-C), 128.3 (2 × Ph-C), 127.7 (2 
× Ph-C), 60.1 (C(CH3)3 quat.), 43.3 (CHN), 24.0 (C(CH3)3), 19.0 (CHI); HRMS (ESI+) m/z Calculated for C12H17INO2S+ [M+H]+ 
366.0019; Found 366.0021. 
4.3. General Procedure C: Synthesis of N-Sulfonyl Iodoaziridines using ClMgCHI2. 
EtMgCl (2 M in THF, 4.50 mL, 9.00 mmol, 3.0 equiv) was added dropwise over 2 minutes to a solution of iodoform (3.54 g, 9.00 
mmol, 3.0 equiv) in THF (34 mL) at −78 °C in the dark. After 10 minutes at −78 °C, a solution of the appropriate imine or 
imine−HSO2Tol adduct (3.00 mmol, 1.0 equiv) in THF (8 mL) was added dropwise over 3 minutes. The reaction was left for 10 
minutes at −78 °C and then warmed to 0 °C in an ice/water bath. After 15 minutes at 0 °C, the reaction was quenched by the addition of 
saturated aqueous sodium bicarbonate solution (100 mL). The aqueous solution was extracted with CH2Cl2 (3 × 100 mL) and the 
organic extracts were combined, dried (Na2SO4), filtered and the solvent removed under reduced pressure. Purification by flash 
chromatography (silica, hexane grading to 10% EtOAc/hexane) afforded the cis-α-iodoaziridine. 
4 .3 .1 .  c is - (±) -2- Iodo-3- (propan-2-y l ) -1 - (4 - to ly l su l fony l )az i r id ine  (15 ) .   
Prepared according to General Procedure C described above, starting from imine−HO2STol adduct 14 (1.14 g, 3.00 mmol). Purification 
by flash chromatography (10% EtOAc/hexane) afforded cis-α-iodoaziridine 15 (930 mg, 85%) as a yellow solid: Rf = 0.21 (10% 
EtOAc/hexane); νmax (film)/cm-1 2963, 2931, 2874, 1597, 1466, 1403, 1329, 1244, 1156, 1089, 1026, 954, 885, 831, 813, 734, 684, 667; 
1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.3 Hz, 2H, 2 × SO2Tol-H), 7.36 (d, J = 8.3 Hz, 2H, 2 × SO2Tol-H), 4.54 (d, J = 5.9 Hz, 1H, 
CHI), 2.46 (s, 3H, SO2Tol-CH3), 2.20 (dd, J = 9.7, 5.9 Hz, 1H, CHN), 1.92 (dqq, J = 9.7, 6.7, 6.7 Hz, 1H, CH(CH3)2), 0.99 (d, J = 6.7 
Hz, 3H, CH(CH3)2), 0.92 (d, J = 6.7 Hz, 3H, CH(CH3)2); 13C NMR (101 MHz, CDCl3) δ 145.1 (SO2Tol-C quat.), 134.3 (SO2TolC-CH3 
quat.), 129.8 (2 × SO2Tol-C), 128.0 (2 × SO2Tol-C), 49.3 (CHN), 31.5 (CH(CH3)2), 21.7 (SO2Tol-CH3), 20.0 (CH3), 17.9 (CH3), 13.8 
(CHI); HRMS (ESI+) m/z Calculated for C12H17INO2S+ [M+H]+: 366.0019; Found: 366.0034. 
4 .3 .2 .  c is - (±) -2- Iodo-3-cyc lohexy l -1 - (4 - to ly l su l fony l )az i r id ine  (17 ) .  
Prepared according to General Procedure C described above, starting from N-[(E)-cyclohexylmethylidene]-4-methyl-benzene-
sulfonamide (796 mg, 3.00 mmol). Purification by flash chromatography (10% EtOAc/hexane) afforded cis-α-iodoaziridine 17 (999 
mg, 82%) as a yellow solid: Rf = 0.18 (10% Et2O/hexane); νmax (film)/cm-1 2926, 2851, 1598, 1450, 1330, 1242, 1158, 1090, 968, 900, 
883, 814, 732, 669; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H, 2 × SO2Tol-H), 7.37 (d, J = 8.2 Hz, 2H, 2 × SO2Tol-H), 4.53 
(d, J = 6.0 Hz, 1H, CHI), 2.47 (s, 3H, SO2Tol-CH3), 2.26 (dd, J = 9.4, 6.0 Hz, 1H, CHCy), 1.84−1.71 (m, 2H, 2 × Cy-H), 1.70−1.62 (m, 
2H, 2 × Cy-H), 1.60−1.53 (m, 1H, Cy-H), 1.33−0.99 (m, 6H, 6 × Cy-H); 13C NMR (101 MHz, CDCl3) δ 145.0 (SO2Tol-C quat.), 134.4 
(SO2TolC-CH3 quat.), 129.8 (2 × SO2Tol-C), 128.0 (2 × SO2Tol-C), 47.8 (CHN), 40.1 (CH), 30.3 (CH2), 28.3 (CH2), 25.9 (CH2), 25.2 
(CH2), 25.1 (CH2), 21.7 (SO2Tol-CH3), 13.5 (CHI); HRMS (ESI+) m/z Calculated for C15H21INO2S+ [M+H]+: 406.0332; Found: 
406.0328. 
4 .3 .3 .  c is - (±) -2- Iodo-3- ( ter t -bu ty l ) -1 - (4 - to ly l su l fony l )az i r id ine  (18 ) .   
Prepared according to General Procedure C described above, starting from N-[(E)-2,2-dimethylpropylidene]-4-methyl-
benzenesulfonamide (718 mg, 3.00 mmol, 1.0 equiv). Purification by flash chromatography (hexane grading to 10% EtOAc/hexane) 
afforded cis-α-iodoaziridine 18 (553 mg, 49%) as a yellow oil: Rf = 0.31 (10% EtOAc/hexane); νmax (film)/cm-1 2964, 2874, 1600, 
1330, 1258, 1158, 1089, 953, 931, 852, 734, 677, 667; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H, 2 × SO2Tol-H), 7.36 (d, J 
= 8.2 Hz, 2H, 2 × SO2Tol-H), 4.36 (d, J = 6.4 Hz, 1H, CHI), 2.45 (s, 3H, SO2Tol-CH3), 2.43 (d, J = 6.4, 1H, HCC(CH3)3), 0.98 (s, 9H, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 145.0 (SO2Tol-C quat.), 134.1 (SO2TolC-CH3 quat.), 129.7 (2 × SO2Tol-C), 128.0 (2 × 
SO2Tol-C), 50.2 (HCC(CH3)3), 31.4 (C(CH3)3 quat.), 27.0 (C(CH3)3), 21.7 (SO2Tol-CH3), 6.6 (CHI); HRMS (ESI+) m/z Calculated for 
C13H19INO2S+ [M+H]+ 380.0181; Found 380.0203. 
4 .3 .4 .  (2R ,3S)-2- Iodo-1-[(R) -2-methy lpropane-2-su l f iny l] -3 -pheny laz i r id ine  (major ,  20 )  and  (2S ,3R)-2-
Iodo-1-[(R) -2-methy lpropane-2-su l f iny l] -3 -pheny laz i r id ine  (minor ,  21 ) .  
Using ClMgCHI2: Prepared according to General Procedure C described above, starting from imine 19 (105 mg, 0.50 mmol). 
Purification by flash chromatography (hexane grading to 10% EtOAc/hexane) on silica gel afforded a mixture of cis-α-iodoaziridines 
(71:29 major:minor) 20 and 21 (101 mg, 58%) as a yellow oil:  
Using LiCHI2: Prepared according to General Procedure B described above, starting from imine 19 (105 mg, 0.50 mmol). Purification 
by flash chromatography (5% EtOAc/hexane) on deactivated basic alumina (activity V) afforded a mixture of cis-α-iodoaziridines 
(85:15 major:minor) 20 and 21 (103 mg, 59%) as a yellow oil. 
Rf = 0.36 (25% EtOAc/hexane); [𝛼]!!" –21.3º (c 0.66, CHCl3; 85:15 major:minor); νmax (film)/cm-1 2960, 2867, 1605, 1495, 1475, 1454, 
1363, 1312, 1238, 1170, 1080, 1026, 906, 847, 817, 791, 758, 699, 676; 20: 1H NMR (400 MHz, CDCl3) δ 7.43–7.33 (m, 5H, 5 × Ph-
H), 4.54 (d, J = 6.0 Hz, 1H, CHI), 3.71 (d, J = 6.0 Hz, 1H, CHPh), 1.20 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 133.8 (Ph-C 
quat.), 128.5 (Ph-C), 128.2 (2 × Ph-C), 128.1 (2 × Ph-C), 57.5 (CHPh), 35.4 (C(CH3)3), 22.6 (C(CH3)3), 17.8 (CHI); 21: 1H NMR (400 
MHz, CDCl3) δ 7.43–7.33 (m, 5H, 5 × Ph-H), 4.83 (d, J = 5.9 Hz, 1H, CHI), 3.30 (d, J = 5.9 Hz, 1H, CHPh), 1.41 (s, 9H, C(CH3)3); 13C 
NMR (101 MHz, CDCl3) δ 134.7 (Ph-C quat.), 128.4 (Ph-C), 128.0 (2 × Ph-C), 127.7 (2 × Ph-C), 58.6 (CHPh), 38.6 (C(CH3)3), 23.3 
(C(CH3)3), 15.4 (CHI); HRMS (ESI+) m/z Calculated for C12H17INOS+ [M+H]+ 350.0070; Found 350.0078.  
4 .3 .5 .  c is - (±) -2- Iodo-3-propy l -1 - (4 - to ly l su l fony l )az i r id ine  (23 ) .  
EtMgCl (2 M in THF, 0.75 mL, 1.50 mmol, 3.0 equiv) was added dropwise over 2 minutes to a solution of iodoform (591 mg, 1.50 
mmol, 3.0 equiv) in THF (6 mL) at −78 °C in the dark. After 10 minutes at −78 °C, a solution of imine−HO2STol adduct 22 (191 mg, 
0.50 mmol) in THF (2 mL) was added dropwise over 3 minutes. The reaction was left for 10 minutes at −78 °C and then warmed to 0 
°C in an ice/water bath. After 15 minutes at 0 °C, the reaction was quenched by the addition of saturated aqueous sodium bicarbonate 
solution (20 mL). The aqueous solution was extracted with CH2Cl2 (3 × 30 mL) and the organic extracts were combined, dried 
(Na2SO4), filtered and the solvent removed under reduced pressure. Purification by flash chromatography (hexane grading to 10% 
EtOAc/hexane) on deactivated basic alumina (activity IV) afforded cis-α-iodoaziridine 23 (80 mg, 44%) as a yellow oil: Rf = 0.23 (10% 
EtOAc/hexane); νmax (film)/cm-1 2960, 2931, 2873, 1598, 1331, 1245, 1160, 1090, 902, 717; 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 
8.3 Hz, 2H, 2 × SO2Tol-H), 7.37 (d, J = 8.3 Hz, 2H, 2 × SO2Tol-H), 4.55 (d, J = 6.0 Hz, 1H, CHI), 2.60−2.55 (m, 1H, CHN), 2.47 (s, 
3H, SO2Tol-CH3), 1.57−1.40 (m, 4H, 2 × CH2), 0.95 (t, J = 7.3 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3) δ 145.0 (SO2Tol-C quat.), 
134.5 (SO2TolC-CH3 quat.), 129.8 (2 × SO2Tol-C), 127.9 (2 × SO2Tol-C), 43.6 (CHN), 33.5 (CH2), 21.7 (SO2Tol-CH3), 19.7 (CH2), 
14.5 (CH3), 13.6 (CHI); HRMS (ESI+) m/z Calculated for C12H17INO2S+ [M+H]+: 366.0019; Found: 366.0031. 
4 .3 .6 .  c is - (±) -2- Iodo-3- (2-methy lpropy l ) -1 - (4 - to ly l su l fony l )az i r id ine  (27 )  and   N- (1 ,1 -Di iodo-4-
methy lpen tan-2-y l ) -4 - to ly l -1 -su l fonamide  (26 ) .  
EtMgCl (2 M in THF, 0.75 mL, 1.50 mmol, 3.0 equiv) was added dropwise over 2 minutes to a solution of iodoform (591 mg, 1.50 
mmol, 3.0 equiv) in THF (6 mL) at −78 °C in the dark. After 10 minutes at −78 °C, a solution of imine−HO2STol adduct 25 (198 mg, 
0.50 mmol) in THF (2 mL) was added dropwise over 3 minutes. The reaction was left for 10 minutes at −78 °C and then warmed to 0 
°C in an ice/water bath. After 15 minutes at 0 °C, the reaction was quenched by the addition of saturated aqueous sodium bicarbonate 
solution (20 mL). The aqueous solution was extracted with CH2Cl2 (3 × 30 mL) and the organic extracts were combined, dried 
(Na2SO4), filtered and the solvent removed under reduced pressure. Purification by flash chromatography (hexane grading to 10% 
EtOAc/hexane) on deactivated basic alumina (activity IV) afforded cis-α-iodoaziridine 27 (83 mg, 44%) as a yellow oil, followed by 
amino gem-diiodide 26 (40 mg, 16%) as a white solid. 
26: Rf = 0.17 (10% EtOAc/hexane); νmax (film)/cm-1 3243, 2959, 1417, 1330, 1162, 1093, 1036, 962, 917, 814, 665; 1H NMR (400 
MHz, CDCl3) δ 7.79 (d, J = 7.9 Hz, 2H, 2 × SO2Tol-H), 7.34 (d, J = 7.9 Hz, 2H, 2 × SO2Tol-H), 5.27−5.26 (m, 1H, CHI2), 4.93 (d, J = 
8.3 Hz, 1H, NH), 2.91−2.84 (m, 1H, CHN), 2.46 (s, 3H, SO2Tol-CH3), 1.70−1.60 (m, 1H, CH), 1.47−1.35 (m, 2H, CH2), 0.88 (t, J = 6.4 
Hz, 3H, CH3), 0.66 (t, J = 6.3 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3) δ 144.1 (SO2Tol-C quat.), 137.3 (SO2TolC-CH3 quat.), 129.9 
(2 × SO2Tol-C), 127.1 (2 × SO2Tol-C), 59.1 (CHN), 43.2 (CH2), 24.1 (CH), 23.3 (CH3), 21.6 (SO2Tol-CH3), 21.2 (CH3), −11.6 (CHI2). 
27: Rf = 0.31 (10% EtOAc/hexane); νmax (film)/cm-1 2956, 2872, 1597, 1467, 1329, 1246, 1158, 1089, 999, 904, 813, 714; 1H NMR 
(400 MHz, CDCl3) δ 7.82 (d, J = 8.3 Hz, 2H, 2 × SO2Tol-H), 7.36 (d, J = 8.3 Hz, 2H, 2 × SO2Tol-H), 4.54 (d, J = 5.9 Hz, 1H, CHI), 
2.63 (dt, J = 7.0, 6.1 Hz, 1H, CHN), 2.46 (s, 3H, SO2Tol-CH3), 1.77−1.67 (m, 1H, CH), 1.51−1.42 (m, 2H, CH2), 0.98 (t, J = 6.7 Hz, 
3H, CH3), 0.95 (t, J = 6.7 Hz, 3H, CH3); 13C NMR (101 MHz, CDCl3) δ 145.0 (SO2Tol-C quat.), 134.5 (SO2TolC-CH3 quat.), 129.8 (2 
× SO2Tol-C), 127.8 (2 × SO2Tol-C), 42.6 (CHN), 40.1 (CH2), 26.3 (CH), 22.5 (CH3), 22.3 (CH3), 21.7 (SO2Tol-CH3), 14.9 (CHI); 
HRMS (ESI+) m/z Calculated for C13H19INO2S+ [M+H]+: 380.0176; Found: 380.0195. 
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